US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pasithea Therapeutics Corp Warrant

0.0368

-0.0005-1.34%

Volume:26.86K

Turnover:1.14K

Market Cap:273.92K

PE:- -

High:0.0500

Open:0.0367

Low:0.0367

Close:0.0373

52wk High:0.1198

52wk Low:0.0108

Shares:7.44M

Float Shares:7.44M

Volume Ratio:0.11

T/O Rate:0.36%

Dividend:- -

Dividend Rate:- -

ROE:-8.41%

ROA:-10.52%

PB:0.01

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Pasithea Therapeutics Corp Warrant

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

- -

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KTTAW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KTTAW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KTTAW\",,,,,undefined,":{"symbol":"KTTAW","market":"US","secType":"STK","nameCN":"Pasithea Therapeutics Corp Warrant","latestPrice":0.0368,"timestamp":1764968400000,"preClose":0.0373,"halted":0,"volume":26855,"delay":0,"floatShares":7443563,"shares":7443563,"eps":0,"marketStatus":"Market Closed","change":-0.0005,"latestTime":"12-05 16:00:00 EST","open":0.0367,"high":0.05,"low":0.0367,"amount":1142.8084,"amplitude":0.356568,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"listingDate":1631678400000,"exchange":"NASDAQ","adjPreClose":0.0373,"volumeRatio":0.10889469559090713},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KTTAW\",,,,,undefined,":{"symbol":"KTTAW","floatShares":7443563,"roa":"-10.52%","roe":"-8.41%","lyrEps":0,"volumeRatio":0.10889469559090713,"shares":7443563,"dividePrice":0,"high":0.05,"amplitude":0.356568,"preClose":0.0373,"low":0.0367,"week52Low":0.0108,"pbRate":"0.01","psRate":"6.48","week52High":0.1198,"institutionHeld":0,"latestPrice":0.0368,"eps":0,"divideRate":0,"volume":26855,"delay":0,"ttmEps":0,"open":0.0367,"prevYearClose":0.0346,"prevWeekClose":0.059,"prevMonthClose":0.059,"prevQuarterClose":0.0169,"fiveDayClose":0.059,"twentyDayClose":0.0199,"sixtyDayClose":0.0137},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KTTAW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KTTAW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KTTAW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":-0.3763},{"period":"1month","weight":0.8492},{"period":"3month","weight":1.3},{"period":"6month","weight":0.84},{"period":"1year","weight":0.4632},{"period":"ytd","weight":0.0636}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.060805},{"month":2,"riseRate":0,"avgChangeRate":-0.287615},{"month":3,"riseRate":0.75,"avgChangeRate":0.126582},{"month":4,"riseRate":0.5,"avgChangeRate":0.012739},{"month":5,"riseRate":0.5,"avgChangeRate":-0.039385},{"month":6,"riseRate":0.25,"avgChangeRate":-0.152142},{"month":7,"riseRate":0.25,"avgChangeRate":0.597648},{"month":8,"riseRate":0.25,"avgChangeRate":-0.176901},{"month":9,"riseRate":0.5,"avgChangeRate":0.550542},{"month":10,"riseRate":0.2,"avgChangeRate":-0.294041},{"month":11,"riseRate":0.4,"avgChangeRate":1.069252},{"month":12,"riseRate":0.2,"avgChangeRate":-0.071323}],"exchange":"NASDAQ","name":"Pasithea Therapeutics Corp Warrant","nameEN":"Pasithea Therapeutics Corp Warrant"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KTTAW\",market:\"US\",,,undefined,":null}}